CALIDI BIOTHERAPEUTICS INC (CLDI) Stock Income Statement
NYSEARCA:CLDI - US3207033099 - Common Stock
1.74 USD
+0.04 (+2.35%)
1.73 USD
-0.01 (-0.57%)
| TTM (2025-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 45.00K | 449.00K | 0.00 | |||
| Minority Interest Expense | 188.00K | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | N/A | 0.00 | 14.00K | 94.00K | 0.00 | |||
| Gross Profit | N/A | 0.00 | 31.00K | 355.00K | 0.00 | |||
| Operating Expenses | 19.98M | 28.99M | 23.16M | 9.96M | 6.77M | |||
| Research and Development | 8.99M | 13.01M | 7.26M | 3.80M | 3.18M | |||
| Selling, General, and Administrative Expenses | 10.99M | 15.98M | 15.90M | 6.16M | 3.59M | |||
| Operating Income | -19.98M | -28.99M | -23.13M | -9.61M | -6.77M | |||
| Interest Income/Expense | -531.00K | -1.07M | -158.00K | -614.00K | -163.00K | |||
| Other Income/Expense | 478.00K | 1.33M | -2.13M | 237.00K | -1.05M | |||
| Non Recurring Items | N/A | -471.00K | 0.00 | -939.00K | 57.00K | |||
| Income Before Taxes | -20.03M | -29.20M | -25.42M | -10.92M | -7.93M | |||
| Income Tax | 9.00K | 16.00K | 11.00K | 11.00K | 4.00K | |||
| Net Income | -19.85M | -29.22M | -25.43M | -10.93M | -7.94M | |||
| EBITDA | -18.98M | -28.60M | -22.87M | -9.45M | -6.67M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -15.16 | -65.49 | -67.13 | -28.87 | -20.95 | |||
| Non GAAP EPS | -5.31 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | 68.89% | 79.06% | N/A | |||
| Profit Margin | N/A | N/A | -56504.44% | -2434.97% | N/A | |||
| Operating Profit Margin | N/A | N/A | -51395.56% | -2139.42% | N/A | |||
All data in USD